MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
-15.65%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$460M
AUM Growth
+$460M
(-18%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $299M | 65.12% | 17,923,892 | – | – |
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $66.4M | 14.44% | 2,067,861 | – | – |
|
3
Vaxcyte
PCVX
$4B
| $47.9M | 10.42% | 1,887,478 | – | – |
|
4
Merus
MRUS
$4.98B
| $35.2M | 7.66% | 1,600,000 | – | – |
|
|
CMPI
5
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $5.96M | 1.3% | 1,501,716 | – | – |
|
|
OBSV
6
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $4.88M | 1.06% | 1,570,000 | – | – |
|